🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
This partially randomized phase Ib/II trial studies the side effects and be...
Status
Terminated
Location
University of Alabama, Birmingham
Start Date
2015-06
Trial ID
NCT02457910
Treatments Being Tested
This research study is evaluating a drug called enzalutamide in combination...
Status
Unknown
Location
Hospital Ramón y Cajal
Start Date
2017-12-27
Trial ID
NCT03196388
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and phar...
Status
Completed
Location
ATTN-Research Pharmacist
Start Date
2012-04-30
Trial ID
NCT01597193
Treatments Being Tested
This randomized phase III trial studies enzalutamide to see how well it wor...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-01-22
Trial ID
NCT01949337
Treatments Being Tested
This Phase I, open-label, dose-finding, multicenter study is designed to de...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-13
Trial ID
NCT02215096
Treatments Being Tested
The purpose of this study is to find out whether talazoparib in combination...
Status
Recruiting
Location
City of Hope
Start Date
2026-05-04
Trial ID
NCT06844383
Treatments Being Tested
Asymptomatic patients with metastatic castrate resistant prostate cancer (m...
Status
Recruiting
Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Start Date
2023-10-04
Trial ID
NCT06059118
Treatments Being Tested
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy...
Status
Completed
Location
Piedmont Cancer Institute, P.C.
Start Date
2019-12-05
Trial ID
NCT04179396
Treatments Being Tested
The purpose of this study is to assess the efficacy, tolerability, safety, ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-01-25
Trial ID
NCT05114746
Treatments Being Tested